Novo Nordisk's analog insulin will be sold cheaply in Walmart
Novo Nordisk will produce an insulin analog for the retail giant Walmart, which will be offering the drug at far lower prices than competing drugs for patients without insurance.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
US retail giant Walmart will soon be selling its own brand of analog insulin, which will be produced by Novo Nordisk, according to Bloomberg News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly welcomes competition for cheap insulin in US
For subscribers
Novo Nordisk wants to innovate in new ways to find cures
For subscribers
.jpg&w=384&q=75)
